Skip to main content

Table 5 Rate ratios (95% CI) for number and days of hospitalisation during three-year follow-up according to type of sarcopenia definition

From: Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study

 Model 1
RR (95% CI)
p–valueModel 2
RR (95% CI)
p–valueModel 3
RR (95% CI)
p–value
Number of hospitalisations
 Sarcopenia (EWGSOP)1.49 (1.00–2.22)0.0481.33 (0.95–1.87)0.0951.31 (0.93–1.83)0.12
 Probable sarcopenia (EWGSOP2)1.46 (1.05–2.03)0.0241.25 (0.91–1.72)0.171.25 (0.91–1.72)0.17
 Sarcopenia (EWGSOP2)1.18 (0.80–1.75)0.411.11 (0.79–1.55)0.541.10 (0.79–1.53)0.57
 Sarcopenia (FNIH)2.10 (1.33–3.33)0.0021.78 (1.07–2.97)0.0261.75 (1.10–2.81)0.019
Days of hospitalisation
 Sarcopenia (EWGSOP)1.63 (0.92–2.90)0.0971.38 (0.83–2.32)0.221.36 (0.81–2.29)0.24
 Probable sarcopenia (EWGSOP2)2.90 (1.86–4.52)< 0.0012.20 (1.42–3.40)< 0.0012.12 (1.36–3.30)0.001
 Sarcopenia (EWGSOP2)1.03 (0.60–1.76)0.911.00 (0.61–1.62)0.991.00 (0.62–1.63)0.99
 Sarcopenia (FNIH)2.59 (1.34–5.03)0.0051.89 (0.97–3.67)0.0621.80 (0.93–3.47)0.079
  1. Negative binomial regression models were used for analyses. Model 1: unadjusted. Model 2: adjusted for age, Charlson index. Model 3: adjusted for age, Charlson index, education, smoking, MMSE. EWGSOP European Working Group on Sarcopenia in Older People [3], EWGSOP2 European Working Group on Sarcopenia in Older People, 2018 update [4], FNIH Foundation for the National Institutes of Health Sarcopenia Project [9], MMSE mini mental state exam
\